Van Houtte Paul, Moretti Luigi, Charlier Florian, Roelandts Martine, Van Gestel Dirk
Department of Radiation Oncology, Institut Jules Bordet, Université Libre Bruxelles, Brussels, Belgium.
Transl Lung Cancer Res. 2021 Apr;10(4):1950-1959. doi: 10.21037/tlcr-20-472.
Preoperative and postoperative radiotherapy (PORT) with or without chemotherapy has been used in non-small cell lung cancer (NSCLC) for decades. Numerous trials have investigated the potential survival benefit of this strategy, but despite greater knowledge of the disease, considerable technological developments in imaging and radiotherapy, and significant progress in surgery, many questions remain unsolved. In this review, we summarize the current knowledge on this problem and discuss issues which still require elucidation.
术前和术后放疗(PORT)联合或不联合化疗已在非小细胞肺癌(NSCLC)中应用了数十年。众多试验研究了该策略潜在的生存获益,但尽管对该疾病有了更多了解,成像和放疗技术有了显著发展,手术也取得了重大进展,许多问题仍未得到解决。在本综述中,我们总结了关于这一问题的现有知识,并讨论了仍需阐明的问题。